Search

everythinglearnresearchcommunity

for

Search:↓

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

A new compound effectively inhibits human 5α-reductase 1.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Compound 15a was effective in inhibiting 5α-reductase.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Finasteride reduces hair growth and is safe for women with excessive hair.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.